CEOs and med-tech execs wrapped up their final presentations Thursday at the 31st annual J.P. Morgan Healthcare conference in San Francisco, as they spoke about topics ranging from acquisitions to restructuring efforts. Firms that spoke on either restructuring or acquisition plans had just recently made med-tech headlines this week for putting some of these measures in place.

SAN FRANCISCO — Med-tech CEOs once again stepped up to the podium at J.P. Morgan's 31st annual healthcare conference to share strategies; briefly reflect on 2012 and discuss plans for 2013. Zimmer (Warsaw, Indiana), Boston Scientific (Natick, Massachusetts) and Illumina (San Diego) were some of the firms featured Tuesday that spoke about upcoming plans.